Per-protocol analysis indicated that patients who received DNA test results before surgery ( 59 out of 178 women in the RGCT group ) opted for direct BLM significantly more often than patients who received usual care ( 22 % vs 9.2 % ; OR 3.09 , CI 1.15-8 .31 , P = 0.03 ) .